Cargando…
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
AIM: Several reports have shown that risperidone increases prolactin concentrations, while aripiprazole decreases prolactin concentrations. The frequency of abnormal prolactin concentrations in patients with schizophrenia receiving these drugs is still unknown. Furthermore, although hyperprolactinem...
Autores principales: | Tasaki, Minami, Yasui‐Furukori, Norio, Yokoyama, Saaya, Shinozaki, Masataka, Sugawara, Norio, Shimoda, Kazutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411320/ https://www.ncbi.nlm.nih.gov/pubmed/34189861 http://dx.doi.org/10.1002/npr2.12190 |
Ejemplares similares
-
Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis
por: Yokoyama, Saaya, et al.
Publicado: (2022) -
Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013) -
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015) -
Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
por: Yasui-Furukori, Norio, et al.
Publicado: (2023) -
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)